Market Overview

Syros Pharmaceuticals Shares Down 12.84%; Wednesday Co. Announced Preclinical Data On SY-1365 Showing 'Significant Anti-Tumor Activity'

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Posted-In: Biotech Movers

 

Related Articles (SYRS)

Partner Center